Similar articles for PMID: 15736466

Year	Number of Results
1897	1
1980	2
1982	3
1986	2
1988	2
1990	1
1991	4
1992	3
1993	3
1994	13
1995	6
1996	13
1997	18
1998	11
1999	21
2000	16
2001	16
2002	15
2003	20
2004	38
2005	16
2006	8
2007	19
2008	16
2009	16
2010	13
2011	10
2012	4
2013	5
2014	5
2015	5
2016	1
2017	3
2018	4
2019	2
2020	2
2021	3
2023	1
2024	0

1

Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer.

Werle B, Kotzsch M, Lah TT, Kos J, Gabrijelcic-Geiger D, Spiess E, Schirren J, Ebert W, Fiehn W, Luther T, Magdolen V, Schmitt M, Harbeck N. Werle B, et al. Anticancer Res. 2004 Nov-Dec;24(6):4147-61. Anticancer Res. 2004. PMID: 15736466 Free article.

2

Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.

Werle B, Lötterle H, Schanzenbächer U, Lah TT, Kalman E, Kayser K, Bülzebruck H, Schirren J, Krasovec M, Kos J, Spiess E. Werle B, et al. Br J Cancer. 1999 Oct;81(3):510-9. doi: 10.1038/sj.bjc.6690723. Br J Cancer. 1999. PMID: 10507778 Free PMC article.

3

Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis.

Offersen BV, Pfeiffer P, Andreasen P, Overgaard J. Offersen BV, et al. Lung Cancer. 2007 Apr;56(1):43-50. doi: 10.1016/j.lungcan.2006.11.018. Epub 2007 Jan 17. Lung Cancer. 2007. PMID: 17207889

4

Plasminogen activator inhibitor type 1 in cytosolic tumor extracts predicts prognosis in low-risk breast cancer patients.

Grøndahl-Hansen J, Christensen IJ, Briand P, Pappot H, Mouridsen HT, Blichert-Toft M, Danø K, Brünner N. Grøndahl-Hansen J, et al. Clin Cancer Res. 1997 Feb;3(2):233-9. Clin Cancer Res. 1997. PMID: 9815678

5

Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue.

Pedersen H, Brünner N, Francis D, Osterlind K, Rønne E, Hansen HH, Danø K, Grøndahl-Hansen J. Pedersen H, et al. Cancer Res. 1994 Sep 1;54(17):4671-5. Cancer Res. 1994. PMID: 8062262

6

Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.

Fox SB, Taylor M, Grøndahl-Hansen J, Kakolyris S, Gatter KC, Harris AL. Fox SB, et al. J Pathol. 2001 Sep;195(2):236-43. doi: 10.1002/path.931. J Pathol. 2001. PMID: 11592104

7

[Influence of overexpressed coagulant and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer].

Chen WH, Wang C, Zhang YH, Yang YH, Zhan HY, Zhang LM. Chen WH, et al. Zhonghua Yi Xue Za Zhi. 2007 Dec 4;87(45):3228-32. Zhonghua Yi Xue Za Zhi. 2007. PMID: 18399120 Chinese.

8

Changes in plasminogen activator inhibitor-1 levels in non-small cell lung cancer.

Pavey SJ, Marsh NA, Ray MJ, Butler D, Dare AJ, Hawson GA. Pavey SJ, et al. Boll Soc Ital Biol Sper. 1996 Nov-Dec;72(11-12):331-40. Boll Soc Ital Biol Sper. 1996. PMID: 9178585

9

The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients.

Foekens JA, Peters HA, Look MP, Portengen H, Schmitt M, Kramer MD, Brünner N, Jänicke F, Meijer-van Gelder ME, Henzen-Logmans SC, van Putten WL, Klijn JG. Foekens JA, et al. Cancer Res. 2000 Feb 1;60(3):636-43. Cancer Res. 2000. PMID: 10676647

10

The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.

Hildenbrand R, Schaaf A. Hildenbrand R, et al. Int J Oncol. 2009 Jan;34(1):15-23. Int J Oncol. 2009. PMID: 19082473

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

323 results

Results by year